Clinical trials
Enrolling by invitation Parkinson Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 9 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Washington University School of Medicine | 3 |
| Doris Wang, MD, PhD | 2 |
| Duke University | 2 |
| Mayo Clinic | 2 |
| AskBio Inc | 1 |
| Aspen Neuroscience | 1 |
| BlueRock Therapeutics | 1 |
| Cedars-Sinai Medical Center | 1 |
| Dennis Turner, M.D. | 1 |
| Endeavor Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 37 |
| Multiple Sclerosis | 4 |
| Neurodegenerative Diseases | 4 |
| Multiple System Atrophy | 3 |
| Stroke | 3 |
| Alzheimer Disease | 2 |
| Anxiety Disorders | 2 |
| Brain Neoplasms | 2 |
| Cognitive Dysfunction | 2 |
| Corticobasal Degeneration | 2 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.